|
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; MSD; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Ana Laura Ortega Granados |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca Spain; MSD Oncology; Roche; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; PharmaMar; Roche; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi |
Speakers' Bureau - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche |
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche Pharma AG |
|
|
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech |
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche/Genentech; Takeda |
Speakers' Bureau - Roche/Genentech |
Research Funding - AstraZeneca Spain (Inst) |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |